pharmaphorum April 3, 2024
Phil Taylor

The FDA has cleared an artificial intelligence algorithm that can detect signs of heart failure in seconds using a digital stethoscope during a standard physical exam.

The algorithm was developed by digital stethoscope maker Eko Health in collaboration with the Mayo Clinic. It looks for low ejection fraction (EF), a reduction in outflow of blood from the heart to the aorta, which is present in approximately 50% of heart failure cases.

If LVEF is 40% or less a patient is considered to have heart failure with reduced ejection fraction (HFrEF), sometimes known as systolic heart failure, which generally has to be diagnosed in a hospital setting.

The Low EF AI means that some cases of heart failure could be spotted...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Patient / Consumer, Provider, Technology
OpenAI CEO Sam Altman: Company Considering ‘Different Open-Source Strategy’
Chinese AI app DeepSeek was downloaded by millions. Deleting it might come next
Forget Billion-Dollar Companies—Will AI Create Billion-Dollar People?
Reid Hoffman enters 'wondrous and terrifying' world of health care with latest AI startup
The future of cardiac monitoring: AI-powered wearables in practice

Share This Article